Company news
Imugene Ltd news in 2016
Imugene Ltd's news releases, calls and decks from 2016, newest first.
Imugene progresses mimotope platform
December 18, 2016
Response to ASX Aware Query
December 15, 2016
Acquisition of immuno-oncology technology
December 12, 2016
Leslie Chong Appointed Chief Executive Officer
November 21, 2016
Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study
November 6, 2016
Imugene Share Placement raises $3.2 million
October 20, 2016
Imugene receives $1.3m R&D Tax Refund
September 22, 2016
Imugene successfully completes preclinical animal studies
September 19, 2016
Imugene Final Cancer Vaccine Doses Delivered to GMP Depot
August 29, 2016
Imugene Receives Approval to Start Gastric Cancer Study
August 21, 2016
Imugene Receives Institutional Review Board approval
August 10, 2016
Imugene Receives Institutional Review Board Approval
July 10, 2016
Regulatory package submission for Her-Vaxx in Hong Kong
April 21, 2016
Imugene Announces Successful Capital Raising
March 30, 2016
Manufacturing Update
March 7, 2016
Partnership to Develop Mimotope Immuno-Oncology Platform
February 11, 2016
Imugene key HER-Vaxx patent granted in Europe
February 10, 2016